You are here

Eli Lilly

Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly

Endpoints

Fri, 04/21/17 - 11:45 am

Valeant Pharmaceuticals

Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

Stat

Thu, 04/20/17 - 09:02 pm

Growth Expected for Eli Lilly’s 1Q17 Revenue

Market Realist

Thu, 04/20/17 - 08:57 pm

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

Endpoints

Tue, 04/18/17 - 08:58 pm

G1 Therapeutics

Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain

Motley Fool

Mon, 04/17/17 - 12:09 pm

rheumatoid arthritis

The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling

Yahoo/Business Insider

Mon, 04/17/17 - 11:32 am

rheumatoid arthritis

Biotech Movers: OncoMed, Incyte, Omeros

TheStreet.com

Mon, 04/17/17 - 11:22 am

small cell lung cancer

Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug

Marketwatch

Fri, 04/14/17 - 10:48 am

rheumatoid arthritis

We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming pricing squabble

Endpoints

Thu, 04/13/17 - 11:48 am

How US Drugmakers Profit From China's Biotech Boom

Investopedia

Thu, 04/13/17 - 11:46 am

Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value

Forbes

Sat, 04/8/17 - 01:09 pm

Barclays Sees Positive Catalysts Ahead for Eli Lilly

TheStreet.com

Sat, 04/8/17 - 01:07 pm

GSK, Sanofi, Bayer and Lilly join parade of advertisers marching off Fox News host O’Reilly’s TV show

Fierce Pharma

Wed, 04/5/17 - 12:03 pm

Rivals multiplying, Pfizer appeals to doctor preferences with Ibrance's latest label win

Fierce Pharma

Tue, 04/4/17 - 10:58 pm

HER-2 negative breast cancer

Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't

Fierce Pharma

Tue, 04/4/17 - 12:13 am

PCSK9 inhibitors

4 Drug Stocks With Big News Coming in April

Motley Fool

Tue, 04/4/17 - 12:11 am

Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much

Fierce Pharma

Sat, 04/1/17 - 08:14 am

Bristol-Myers Squibb

Drugmaker Lilly to invest $850 mln in U.S. operations in 2017

Yahoo/Reuters

Fri, 03/24/17 - 11:32 am

[video]Eli Lilly CEO Ricks Says AHCA Won't Hurt Drug Prices

Bloomberg

Fri, 03/24/17 - 10:08 am

American Health Care Act

7 Pharma Plays With Emerging Market Potential

Barron's

Wed, 03/22/17 - 10:59 pm

emerging markets

Bristol-Myers Squibb

Pages